Blockade of angiotensin type 2 receptors decreases diabetes-associated atherosclerosis

被引：0
|
作者：
Koitka, A. [1 ]
Koh, P. [1 ]
Jandeleit-Dahm, K. [1 ]
Cooper, M. E. [1 ]
Allen, T. J. [1 ]
机构：
[1] Baker Heart Res Inst, Diabet Complicat Lab, Melbourne, Vic, Australia
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0209
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] BLOCKADE OF THE ANGIOTENSIN TYPE 2 (AT2) RECEPTOR DECREASES DIABETES-ASSOCIATED ATHEROSCLEROSIS
    Koitka, A.
    Koh, P.
    Jandeleit-Dahm, K. A.
    Cooper, M. E.
    Allen, T. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 13 - 13
  • [2] Compound 21, an angiotensin II type 2 receptor agonist, is protective in experimental diabetes-associated atherosclerosis
    Allen, T.
    Koulis, C.
    Steckelings, U.
    Unger, T.
    Jandeleit-Dahm, K.
    Cooper, M.
    Chow, B. S. M.
    DIABETOLOGIA, 2016, 59 : S115 - S115
  • [3] The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
    Bryna S. M. Chow
    Christine Koulis
    Pooja Krishnaswamy
    Ulrike M. Steckelings
    Thomas Unger
    Mark E. Cooper
    Karin A. Jandeleit-Dahm
    Terri J. Allen
    Diabetologia, 2016, 59 : 1778 - 1790
  • [4] The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
    Chow, Bryna S. M.
    Koulis, Christine
    Krishnaswamy, Pooja
    Steckelings, Ulrike M.
    Unger, Thomas
    Cooper, Mark E.
    Jandeleit-Dahm, Karin A.
    Allen, Terri J.
    DIABETOLOGIA, 2016, 59 (08) : 1778 - 1790
  • [5] PPARs and diabetes-associated atherosclerosis
    Calkin, A. C.
    Jandeleit-Dahm, K. A.
    Sebekova, E.
    Allen, T. J.
    Mizrahi, J.
    Cooper, M. E.
    Tikellis, C.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (26) : 2736 - 2741
  • [6] Type 2 diabetes-associated genes
    Kriebel, J.
    Grallert, H.
    Illig, T.
    DIABETOLOGE, 2012, 8 (01): : 26 - +
  • [7] Macrophage immunometabolism in diabetes-associated atherosclerosis
    dos Santos, Bernardo Gindri
    Goedeke, Leigh
    IMMUNOMETABOLISM, 2023, 5 (04) : E00032
  • [8] Imatinib attenuates diabetes-associated atherosclerosis
    Lassila, M
    Allen, TJ
    Cao, ZM
    Thallas, V
    Jandeleit-Dahm, KA
    Candido, R
    Cooper, ME
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 935 - 942
  • [9] The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes
    Redondo, Maria J.
    Evans-Molina, Carmella
    Steck, Andrea K.
    Atkinson, Mark A.
    Sosenko, Jay
    DIABETES CARE, 2019, 42 (08) : 1357 - 1364
  • [10] Risks of Diabetes-associated Comorbidities in Subgroups of Type 2 Diabetes
    Zaharia, Oana-Patricia
    Marx, Nikolaus
    Kelm, Malte
    Roden, Michael
    AKTUELLE KARDIOLOGIE, 2024, 13 (04) : 257 - 262
12345